Development of a Synthetic Method for [68Ga]Ga-FAPI-04 Using a Cassette-based Synthesizer

[68Ga]Ga-FAPI-04 is a promising radiopharmaceutical that binds specifically to fibroblast activation protein, which is overexpressed in more than 90% of malignant epithelial tumors but not in normal healthy tissue. This study aimed to develop an efficient method for producing 68Ga-labelled FAPI-04 u...

Full description

Bibliographic Details
Published in:	Korean Journal of Clinical Laboratory Science
Main Authors:	Jun Young PARK, Won Jun KANG
Format:	Article
Language:	English
Published:	The Korean Society for Clinical Laboratory Science 2024-03-01
Subjects:	fibroblast activation protein inhibitor [68ga]ga-fapi-04 gallium-68 radiopharmaceuticals
Online Access:	http://www.kjcls.org/journal/view.html?doi=10.15324/kjcls.2024.56.1.43

Similar Items

Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer
by: Hemantha Mallapura, et al.
Published: (2023-12-01)

Dynamic PET/CT Imaging of 68Ga-FAPI-04 in Chinese Subjects
by: Shuailiang Wang, et al.
Published: (2021-03-01)

On the Optimization of the Protocol for Automated Radiosyntheses of [68Ga]Ga-Pentixafor, [68Ga]Ga-FAPI-4 and [68Ga]Ga-DOTATATE in a Modular-Lab Standard
by: Sreeja Menon, et al.
Published: (2024-07-01)

Development of an Automated Synthesizer for the Routine Production of Ga-68 Radiopharmaceuticals
by: Jun Young PARK, et al.
Published: (2023-12-01)

Automated Synthesis of [<sup>68</sup>Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
by: Elisabeth Plhak, et al.
Published: (2023-08-01)

[68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis
by: Qingqing Pan, et al.
Published: (2024-01-01)

A retrospective study of 68Ga-FAPI PET/CT in differentiating the nature of pulmonary lesions
by: Yang Xie, et al.
Published: (2024-05-01)

Development of a versatile [68Ga]Ga-FAPI-46 automated synthesis suitable to multi-elutions of germanium-68/gallium-68 generators
by: Louis-Paul Paty, et al.
Published: (2024-07-01)

In Vivo Fibroblast Activation of Systemic Sarcoidosis: A <sup>68</sup>Ga-FAPI-04 PET/CT Imaging Study
by: Jingnan Wang, et al.
Published: (2023-04-01)

Comparison of Diagnostic Efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT for Staging and Restaging of Gastric Cancer
by: Shumao Zhang, et al.
Published: (2022-07-01)

Comparison of 68Ga-FAPI-04 PET/CT with CECT in the evaluation of peritoneal metastases from gastrointestinal cancers and impact on clinical decision-making
by: Yushan Zhou, et al.
Published: (2025-07-01)

68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
by: Hao Wang, et al.
Published: (2021-06-01)

[<sup>68</sup>Ga]Ga-DOTAGA-Glu(FAPi)<sub>2</sub> Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging
by: Julie van Krimpen Mortensen, et al.
Published: (2024-09-01)

Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma
by: Haoyuan Ding, et al.
Published: (2022-12-01)

Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types
by: Ammar Alfteimi, et al.
Published: (2022-07-01)

Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial
by: Morten Bentestuen, et al.
Published: (2024-06-01)

AUTOMATED SYNTHESIS AND IN VITRO STUDIES OF [68GA]GA-FAPI-46 IN HOSPITAL RADIOPHARMACY
by: Leonardo Lima Fuscaldi, et al.
Published: (2024-04-01)

<sup>68</sup>Ga Extemporaneous Preparations in Radiopharmacy
by: Marzia Rizzello, et al.
Published: (2025-06-01)

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
by: Lucia Zanoni, et al.
Published: (2024-11-01)

Evaluation of Cyclotron Solid Target Produced Gallium-68 Chloride for the Labeling of [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>68</sup>Ga]Ga-DOTATOC
by: Michał Jagodziński, et al.
Published: (2025-08-01)

PET/CT WITH 68GA-FAPI46 FOR THE DETECTION OF PRIMARY AND METASTATIC LESIONS IN PATIENTS WITH DIFFERENT TYPES OF CANCER. INITIAL EXPERIENCE
by: Lilian Yuri Itaya Yamaga, et al.
Published: (2025-05-01)

Good practices for 68Ga radiopharmaceutical production
by: Bryce J. B. Nelson, et al.
Published: (2022-10-01)

68Ga-FAPI PET/CT for diagnostic accuracy and therapeutic response assessment in bleomycin-induced pulmonary fibrosis: an integrated preclinical study
by: Rui Sun, et al.
Published: (2025-06-01)

Fully automated radiosynthesis of [68Ga]Ga-FAPI-46 with cyclotron produced gallium
by: Adam J. Rosenberg, et al.
Published: (2023-10-01)

Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)<sub>2</sub>
by: Tilman Läppchen, et al.
Published: (2024-06-01)

Diagnostic performance of [68Ga]Ga-FAPI-04 PET vs. [18F]FDG PET in detecting lymph node metastasis in digestive system cancers: a head-to-head comparative meta-analysis
by: Huo Li, et al.
Published: (2025-03-01)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
by: Umut Elboga, et al.
Published: (2022-02-01)

Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging
by: Timofei Rusu, et al.
Published: (2023-10-01)

Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)
by: Rebecca Rizzo, et al.
Published: (2025-08-01)

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Lukas Greifenstein, et al.
Published: (2022-08-01)

Head-to-head comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the evaluation of tonsil cancer and lymph node metastases: a single-centre retrospective study
by: Mengjing Ji, et al.
Published: (2024-05-01)

[68Ga]Ga-FAPI PET/CT in brain tumors: comparison with [18F]F-FDG PET/CT
by: Ya Liu, et al.
Published: (2024-09-01)

Evaluation of the Efficacy and Safety of the ITM 68Ge/68Ga Generator After its Recommended Shelf-life
by: Tossaporn Sriprapa, et al.
Published: (2023-10-01)

Production and Quality Control of [<sup>68</sup>Ga]Ga-FAPI-46: Development of an Investigational Medicinal Product Dossier for a Bicentric Clinical Trial
by: Alessandro Cafaro, et al.
Published: (2025-09-01)

Head-to-head comparison of 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in the evaluation of primary digestive system cancer: a systematic review and meta-analysis
by: Jiqi Ouyang, et al.
Published: (2023-06-01)

Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
by: Silvia Migliari, et al.
Published: (2023-02-01)

Iliopsoas fibrosis after revision of total hip arthroplasty revealed by 68Ga-FAPI PET/CT: a case report
by: Yiqun Wang, et al.
Published: (2024-02-01)

Rapid Concentration of Ga-68 and Proof-of-Concept Microscale Labeling of [<sup>68</sup>Ga]Ga-PSMA-11 in a Droplet Reactor
by: Yingqing Lu, et al.
Published: (2024-09-01)

Non-specific uptake of 68Ga-FAPI PET/CT in the pancreas and its related factor: a retrospective, single-center study
by: Liu Xiao, et al.
Published: (2025-10-01)

Novel <sup>68</sup>Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast
by: Arsyangela Verena, et al.
Published: (2023-03-01)